B
Brian R. Berry
Researcher at Royal Jubilee Hospital
Publications - 30
Citations - 1957
Brian R. Berry is an academic researcher from Royal Jubilee Hospital. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 14, co-authored 30 publications receiving 1746 citations. Previous affiliations of Brian R. Berry include BC Cancer Agency & Vancouver Island Health Authority.
Papers
More filters
Journal ArticleDOI
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H. Sehn,Brian R. Berry,Mukesh Chhanabhai,Catherine Fitzgerald,Karamjit Gill,Paul Hoskins,Richard Klasa,Kerry J. Savage,Tamara Shenkier,Judy Sutherland,Randy D. Gascoyne,Joseph M. Connors +11 more
TL;DR: A retrospective analysis of patients with DLBCL treated with R-CHOP to assess the value of the IPI in the era of immunochemotherapy found it to be a clinically useful prognostic index that may help guide treatment planning and interpretation of clinical trials.
Journal ArticleDOI
Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Laurie H. Sehn,David Scott,Mukesh Chhanabhai,Brian R. Berry,Anna Ruskova,Leanne Berkahn,Joseph M. Connors,Randy D. Gascoyne +7 more
TL;DR: A retrospective analysis of the prognostic impact of bone marrow involvement in an unselected population of patients with newly diagnosed DLBCL treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone emphasizes the need for accurate staging assessment of bone stem cell involvement inDLBCL.
Journal ArticleDOI
Organochlorines and risk of non-Hodgkin lymphoma.
John J. Spinelli,Carmen H. Ng,Jean-Philippe Weber,Joseph M. Connors,Randy D. Gascoyne,Agnes S. Lai,Angela Brooks-Wilson,Nhu D. Le,Brian R. Berry,Richard P. Gallagher +9 more
TL;DR: The results provide further evidence that organochlorines contribute to NHL risk and six pesticide analytes showed a significant association with NHL.
Journal ArticleDOI
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma
Kenneth S. Wilson,Laurie H. Sehn,Brian R. Berry,Mukesh Chhanabhai,Catherine Fitzgerald,Karamjit Gill,Richard Klasa,Brian Skinnider,Judy Sutherland,Joseph M. Connors,Randy D. Gascoyne +10 more
TL;DR: The addition of rituximab to CHOP chemotherapy negates the adverse prognostic influence of BCL-2 protein expression on progression free and overall survival in DLBCL.
Journal ArticleDOI
Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention.
Simon D. Robinson,Christian Janssen,Eric Fretz,Brian R. Berry,Alex Chase,Anthony Della Siega,Ronald G. Carere,Anthony Fung,Gerald Simkus,W. Peter Klinke,J. David Hilton +10 more
TL;DR: Red blood cell transfusion is associated with increased 30-day mortality in patients undergoing PCI and although current transfusion practice permits RBC storage for up to 42 days, the use of older red cells may pose an additional hazard to this patient group.